Global phosphoproteome (phospho-Ser/Thr/Tyr) profiling showed that ablation of TBK1 expression in KRAS mutant lung cancers leads to compensatory activation of a panel of receptor tyrosine kinases including EGFR and MET [14]. Here, EGFR is linked to lung carcinoma.